Advertisement
Research Article| Volume 334, ISSUE 1-2, P48-54, November 15, 2013

A follow up study of non-demented patients with primary visual cortical hypometabolism: Prodromal dementia with Lewy bodies

  • Hiroshige Fujishiro
    Correspondence
    Corresponding author at: PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, Juntendo University School of Medicine, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan. Tel.: +81 3 5632 3111; fax: +81 3 5632 3728.
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan

    Department of Psychiatry, Juntendo University School of Medicine, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Eizo Iseki
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan

    Department of Psychiatry, Juntendo University School of Medicine, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Koji Kasanuki
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan

    Department of Psychiatry, Juntendo University School of Medicine, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Yuhei Chiba
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan

    Department of Psychiatry, Juntendo University School of Medicine, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Kazumi Ota
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Norio Murayama
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
  • Kiyoshi Sato
    Affiliations
    PET/CT Dementia Research Center, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo 136-0075, Japan
    Search for articles by this author
Published:August 07, 2013DOI:https://doi.org/10.1016/j.jns.2013.07.013

      Abstract

      We previously reported non-demented patients with glucose hypometabolism in the primary visual cortex (PVC), which is the preferentially affected region in patients with dementia with Lewy bodies (DLB). It remains unknown, however, whether these patients represent a prodromal DLB state. Eleven non-demented patients who attended our memory clinic for more than three years (mean follow-up period: 44 ± 5 months) were examined. All the patients had glucose hypometabolism in the PVC on [18F]-fluoro-d-glucose (FDG) positron emission tomography (PET) scans at baseline. Four patients, including one with a clinical history of occipital bleeding, exhibited no core or suggestive features of DLB. Seven patients reported recurrent nocturnal dream-enactment behavior, which is consistent with probable rapid eye movement (REM) sleep behavior disorder (RBD). The condition of the patient with occipital bleeding was stable, which is consistent with an underlying non-neurodegenerative disorder. Of the remaining 10 patients, 5 had stable cognitive conditions (non-converters) and 5 exhibited progression to dementia (converters). The clinical diagnoses of 4 patients with probable RBD were changed to probable DLB. Despite no differences in psychological profiles at baseline between non-converters and converters, the initial pattern of cortical metabolism differed: converters had lower glucose hypometabolism in the parietal and the lateral occipital cortex compared to non-converters. The metabolic reduction in the PVC is present in patients with prodromal DLB. Moreover, the spatial profiles of reduced glucose metabolism at baseline could help to define the distinct prognostic subgroup that has a greater risk of conversion to DLB.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McKeith I.G.
        • Dickson D.W.
        • Lowe J.
        • Emre M.
        • O'Brien J.T.
        • Feldman H.
        • et al.
        Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium.
        Neurology. 2005; 65: 1863-1872
        • Mosconi L.
        • Tsui W.H.
        • Herholz K.
        • Pupi A.
        • Drzezga A.
        • Lucignani G.
        • et al.
        Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
        J Nucl Med. 2008; 49: 390-398
        • Albert M.S.
        • DeKosky S.T.
        • Dickson D.
        • Dubois B.
        • Feldman H.H.
        • Fox N.C.
        • et al.
        The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging—Alzheimer's Association workgroup.
        Alzheimer's Dement. 2011; 7: 270-279
        • McKhann G.M.
        • Knopman D.S.
        • Chertkow H.
        • Hyman B.T.
        • Jack Jr., C.R.
        • Kawas C.H.
        • et al.
        The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging—Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
        Alzheimer's Dement. 2011; 7: 263-269
        • Jicha G.A.
        • Schmitt F.A.
        • Abner E.
        • Nelson P.T.
        • Cooper G.E.
        • Smith C.D.
        • et al.
        Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease.
        Neurobiol Aging. 2010; 31: 1805-1813
        • Molano J.
        • Boeve B.
        • Ferman T.
        • Smith G.
        • Parisi J.
        • Dickson D.
        • et al.
        Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study.
        Brain. 2010; 133: 540-556
        • Fujishiro H.
        • Iseki E.
        • Nakamura S.
        • Kasanuki K.
        • Chiba Y.
        • Ota K.
        • et al.
        Dementia with Lewy bodies: early diagnostic challenges.
        Psychogeriatrics. 2013; 13: 128-138
        • Minoshima S.
        • Foster N.L.
        • Sima A.A.
        • Frey K.A.
        • Albin R.L.
        • Kuhi D.E.
        Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.
        Ann Neurol. 2001; 50: 358-365
        • Fujishiro H.
        • Iseki E.
        • Murayama N.
        • Ryoko Yamamoto
        • Higashi S.
        • Kasanuki K.
        • et al.
        Diffuse occipital hypometabolism on [18F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?.
        Psychogeriatrics. 2010; 10: 144-152
        • Fujishiro H.
        • Iseki E.
        • Kasanuki K.
        • Murayama N.
        • Ota K.
        • Suzuki M.
        • et al.
        Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
        Int J Geriatr Psychiatry. 2012; 27: 1138-1146
        • Dugger B.N.
        • Boeve B.F.
        • Murray M.E.
        • Parisi J.E.
        • Fujishiro H.
        • Dickson D.W.
        • et al.
        Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies.
        Mov Disord. 2012; 27: 72-78
        • Boeve B.F.
        REM sleep behavior disorder: updated review of the core features, the RBD-neurodegenerative disease association, evolving concepts, controversies, and future directions.
        Ann N Y Acad Sci. 2010; 1184: 15-54
        • Fahn S.
        • Elton R.L.
        UPDRS development committee. The unified Parkinson's disease rating scale.
        in: Fahn S. Marsden C.D. Calne D.B. Goldstein M. Recent developments in Parkinson's disease. Macmillan Healthcare Information, Florham Park, NJ1987: 153-163
        • Louis E.D.
        • Schupf N.
        • Manly J.
        • Marder K.
        • Tang M.X.
        • Mayeux R.
        Association between mild Parkinsonian signs and mild cognitive impairment in a community.
        Neurology. 2005; 64: 1157-1161
        • Miyamoto T.
        • Miyamoto M.
        • Suzuki K.
        • Nishibayashi M.
        • Iwanami M.
        • Hirata K.
        123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
        Sleep. 2008; 31: 717-723
        • Yoshita M.
        • Taki J.
        • Yokoyama K.
        • Noguchi-Shinohara M.
        • Matsumoto Y.
        • Nakajima K.
        • et al.
        Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
        Neurology. 2006; 66: 1850-1854
        • Scheltens P.
        • Leys D.
        • Barkhof F.
        • Huglo D.
        • Weinstein H.C.
        • Vermersch P.
        • et al.
        Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
        J Neurol Neurosurg Psychiatry. 1992; 55: 967-972
        • Fazekas F.
        • Kleinert R.
        • Offenbacher H.
        • Payer F.
        • Schmidt R.
        • Kleinert G.
        • et al.
        The morphologic correlate of incidental punctuate white matter hyperintensities on MR images.
        Am J Neuroradiol. 1991; 2: 915-921
        • Iseki E.
        • Murayama N.
        • Yamamoto R.
        • Fujishiro H.
        • Suzuki M.
        • Kawano M.
        • et al.
        Construction of a 18F-FDG PET normative database of Japanese healthy elderly subjects and its application to demented and mild cognitive impairment patients.
        Int J Geriatr Psychiatry. 2010; 25: 352-361
        • Minoshima S.
        • Frey K.A.
        • Koeppe R.A.
        • Foster N.L.
        • Kuhl D.E.
        A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
        J Nucl Med. 1995; 36: 1238-1248
        • Mizumura S.
        • Kumita S.
        • Cho K.
        • Ishihara M.
        • Nakajo H.
        • Toba M.
        • et al.
        Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation.
        Ann Nucl Med. 2003; 17: 289-295
        • Tiraboschi P.
        • Salmon D.P.
        • Hansen L.A.
        • et al.
        What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?.
        Brain. 2006; 129: 729-735
        • Louis E.D.
        • Bennett D.A.
        Mild Parkinsonian signs: an overview of an emerging concept.
        Mov Disord. 2007; 22: 1681-1688
        • Hughes A.J.
        • Daniel S.E.
        • Kilford L.
        • Lees A.J.
        Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
        J Neurol Neurosurg Psychiatry. 1992; 55: 181-184
        • Lim S.M.
        • Katsifis A.
        • Villemagne V.L.
        • Best R.
        • Jones G.
        • Saling M.
        • et al.
        The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
        J Nucl Med. 2009; 50: 1638-1645
        • Dubois B.
        • Burn D.
        • Goetz C.
        • Aarsland D.
        • Brown R.G.
        • Broe G.A.
        • et al.
        Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
        Mov Disord. 2007; 22: 2314-2324
        • Sinha N.
        • Firbank M.
        • O'Brien J.T.
        Biomarkers in dementia with Lewy bodies: a review.
        Int J Geriatr Psychiatry. 2012; 27: 443-453
        • Fujishiro H.
        • Nakamura S.
        • Kitazawa M.
        • Sato K.
        • Iseki E.
        Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy.
        J Neurol Sci. 2012; 315: 115-119
        • Dickson D.W.
        • Fujishiro H.
        • DelleDonne A.
        • Menke J.
        • Ahmed Z.
        • Klos K.J.
        • et al.
        Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
        Acta Neuropathol. 2008; 115: 437-444
        • Fujishiro H.
        • Frigerio R.
        • Burnett M.
        • Klos K.J.
        • Josephs K.A.
        • Delledonne A.
        • et al.
        Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease.
        Mov Disord. 2008; 23: 1085-1092
        • Ferman T.J.
        • Boeve B.F.
        • Smith G.E.
        • Lin S.C.
        • Silber M.H.
        • Pedraza O.
        • et al.
        Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies.
        Neurology. 2011; 77: 875-882
        • Postuma R.B.
        • Gagnon J.F.
        • Vendette M.
        • Fantini M.L.
        • Massicotte-Marquez J.
        • Montplaisir J.
        Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
        Ann Neurol. 2012; 71: 560-568
        • Fujishiro H.
        • Umegaki H.
        • Isojima D.
        • Akatsu H.
        • Iguchi A.
        • Kosaka K.
        Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
        Acta Neuropathol. 2006; 111: 109-114
        • Bohnen N.I.
        • Albin R.L.
        The cholinergic system and Parkinson disease.
        Behav Brain Res. 2011; 221: 564-573
        • Shimada H.
        • Hirano S.
        • Shinotoh H.
        • Aotsuka A.
        • Sato K.
        • Tanaka N.
        • et al.
        Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
        Neurology. 2009; 73: 273-278
        • Postuma R.B.
        • Gagnon J.F.
        • Vendette M.
        • Fantini M.L.
        • Massicotte-Marquez J.
        • Montplaisir J.
        Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.
        Neurology. 2009; 72: 1296-1300
        • Postuma R.B.
        • Bertrand J.-A.
        • Montplaisir J.
        • Desjardins C.
        • Vendette M.
        • Romenets S.R.
        • et al.
        Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study.
        Mov Disord. 2012; 27: 720-726
        • Gagnon J.F.
        • Vendette M.
        • Postuma R.B.
        • Desjardins C.
        • Massicotte-Marquez J.
        • Panisset M.
        • et al.
        Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease.
        Ann Neurol. 2009; 66: 39-47
        • Mukaetoval-Ladinska E.B.
        • Andras A.
        • Milne J.
        • Abdel-All Z.
        • Borr I.
        • Jaros E.
        • et al.
        Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.
        J Neuropathol Exp Neurol. 2013; 72: 53-60
        • Satoh M.
        • Ishikawa H.
        • Meguro K.
        • Kasuya M.
        • Ishii H.
        • Yamaguchi S.
        Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with Lewy bodies: the Osaki-Tajiri project.
        Eur Neurol. 2010; 64: 337-344
        • Halliday G.M.
        • McCann H.
        The progression of pathology in Parkinson's disease.
        Ann N Y Acad Sci. 2010; 16: 653-661
        • Fujishiro H.
        • Iseki E.
        • Higashi S.
        • Kasanuki K.
        • Murayama N.
        • Togo T.
        • et al.
        Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
        Neurosci Lett. 2010; 486: 19-23
        • Gomperts S.N.
        • Locascio J.J.
        • Minafra B.
        • Santarlasci A.L.
        • Rentz D.M.
        • Maye J.
        • et al.
        Brain amyloid and cognition in Lewy body diseases.
        Mov Disord. 2012; 27: 965-973
        • Kantarci K.
        • Lowe V.J.
        • Boeve B.F.
        • Weigand S.D.
        • Senjem M.L.
        • Przybelski S.A.
        • et al.
        Multimodality imaging characteristics of dementia with Lewy bodies.
        Neubiol Aging. 2012; 33: 2091-2105
        • Nelson P.T.
        • Jicha G.A.
        • Kryscio R.J.
        • Abner E.L.
        • Schmitt F.A.
        • Cooper G.
        • et al.
        Low sensitivity in clinical diagnoses of dementia with Lewy bodies.
        J Neurol. 2010; 257: 359-366